Expressions of TRPV1 in Airway of Asthmatics

NCT02952066 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-06-14

No results posted yet for this study

Summary

The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.

Conditions

  • Moderate Persistent Asthma
  • Severe Persistent Asthma
  • Nodule Solitary Pulmonary
  • Pulmonary Atelectasis

Interventions

PROCEDURE

Bronchial biopsy

Bronchial tissue taken during biopsy

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • Lu Yuan Lee

    lead OTHER

Principal Investigators

  • Lu-Yan Lee, PhD · University of Kentucky

  • Mehdi Khosravi, MD · University of Kentucky

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-20
Primary Completion
2018-11-20
Completion
2018-11-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02952066 on ClinicalTrials.gov